Professor of Medicine at Harvard Medical School and Clinical Director for the Center for Neuro-Oncology at the Dana-Farber / Harvard Cancer Institute. Dr. Reardon is an active researcher in the design and implementation of clinical trials for neuro-oncology and the pre-clinical evaluation of promising therapeutics for CNS tumors.